Adapting Clinical Trial Protocol in Response to COVID-19
VirTrial
MAY 21, 2020
Based on recent SCRS survey data , a vast majority of research sites (58%) anticipate that COVID-19 will negatively affect their clinical trial enrollment and nearly half of respondents (47%) feel COVID-19 will have a negative effect on retention. With the number of new cases increasing daily, these expectations are, unfortunately, likely to be correct. .
Let's personalize your content